Empagliflozin (Jardiance) – Diabetes & Heart Health

What is Empagliflozin?

Empagliflozin, sold under the brand name Jardiance, is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that helps lower blood sugar levels in adults with type 2 diabetes. It also reduces the risk of heart failure and kidney complications in diabetic patients.

Benefits of Empagliflozin (Jardiance)

• Controls blood sugar: Helps lower glucose levels by increasing sugar excretion through urine.
• Reduces heart failure risk: Supports cardiovascular health in diabetic patients.
• Aids in weight loss: Helps promote slight weight reduction in some patients.
• Protects kidneys: Lowers the risk of kidney complications in diabetes.

Jardiance is taken once daily, often as part of a complete diabetes management plan.